A detailed history of Hsbc Holdings PLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 7,265 shares of AKRO stock, worth $226,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,265
Holding current value
$226,668
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.45 - $29.34 $155,834 - $213,155
7,265 New
7,265 $208,000
Q2 2022

Aug 11, 2022

BUY
$8.0 - $15.01 $104,512 - $196,090
13,064 New
13,064 $124,000
Q4 2019

Feb 14, 2020

SELL
$17.37 - $27.27 $469,233 - $736,671
-27,014 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$16.89 - $29.88 $456,266 - $807,178
27,014 New
27,014 $615,000

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.45B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.